|
|
Prepublished online as a Blood First Edition Paper on November 21, 2002; DOI 10.1182/blood-2002-07-2113.

Submitted July 17, 2002
Accepted October 15, 2002
Adenosine affects expression of membrane molecules, cytokine, and chemokine release, and the T cell stimulatory capacity of human dendritic cells
Elisabeth Panther, Silvia Corinti, Marco Idzko, Yared Herouy, Matthias Napp, Andrea la Sala, Giampiero Girolomoni, and Johannes Norgauer*
Department of Experimental Dermatology, University of Freiburg, Freiburg, Germany
Department of Pneumology, University of Freiburg, Freiburg, Germany
Istituto Dermopatico dell`Immacolata, Laboratory of Immunology, Rome, Italy
* Corresponding author; email: norgauer{at}haut.ukl.uni-freiburg.de.
Dendritic cells (DC) express functional purinergic type 1 receptors, but the effects of adenosine in these antigen presenting cells have been only marginally investigated. Here, we further characterized the biological activity of adenosine in immature DC (iDC) and lipopolysaccharide (LPS)-matured DC (mDC). Chronic stimulation with adenosine enhanced the macropinocytotic activity and the membrane expression of CD80, CD86, MHC class I and HLA-DR molecules on iDC. Adenosine also increased LPS-induced CD54, CD80, MHC class I and HLA-DR molecule expression in mDC. In addition, adenosine dose-dependently inhibited tumor necrosis factor and interleukin (IL)-12 release, whereas enhanced the secretion of IL-10 from mDC. The use of selective receptor agonists revealed that the modulation of the cytokine and cell surface marker profile was due to activation of A2 adenosine receptor. Functionally, adenosine reduced the allostimmulatory capacity of iDC, but not of mDC. More important, DC matured in the presence of adenosine had a reduced capacity to induce Th1 polarization of naive CD4+ T lymphocytes. Finally, adenosine augmented the release of the chemokine CCL17 and inhibited CXCL10 production by mDC. In aggregate, the results provide initial evidence that adenosine diminishes the capacity of DC to initiate and amplify Th1 immune responses.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Mandapathil, M. J. Szczepanski, M. Szajnik, J. Ren, D. E. Lenzner, E. K. Jackson, E. Gorelik, S. Lang, J. T. Johnson, and T. L. Whiteside
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Clin. Cancer Res.,
October 15, 2009;
15(20):
6348 - 6357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Wilson, W. G. Ross, O. N. Agbai, R. Frazier, R. A. Figler, J. Rieger, J. Linden, and P. B. Ernst
The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
J. Immunol.,
April 15, 2009;
182(8):
4616 - 4623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jeffe, K. A. Stegmann, F. Broelsch, M. P. Manns, M. Cornberg, and H. Wedemeyer
Adenosine and IFN-{alpha} synergistically increase IFN-{gamma} production of human NK cells
J. Leukoc. Biol.,
March 1, 2009;
85(3):
452 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Csoka, L. Himer, Z. Selmeczy, E. S. Vizi, P. Pacher, C. Ledent, E. A. Deitch, Z. Spolarics, Z. H. Nemeth, and G. Hasko
Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function
FASEB J,
October 1, 2008;
22(10):
3491 - 3499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Novitskiy, S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, Y. Huang, O. Y. Tikhomirov, M. R. Blackburn, I. Biaggioni, D. P. Carbone, I. Feoktistov, et al.
Adenosine receptors in regulation of dendritic cell differentiation and function
Blood,
September 1, 2008;
112(5):
1822 - 1831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. L. Joachims, S. T. McGee, E. Maeda, R. P. McEver, T. Tanaka, M. Miyasaka, et al.
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
J. Immunol.,
May 1, 2008;
180(9):
6288 - 6296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hasko and P. Pacher
A2A receptors in inflammation and injury: lessons learned from transgenic animals
J. Leukoc. Biol.,
March 1, 2008;
83(3):
447 - 455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bendz, S. C. Ruhland, M. J. Pandya, O. Hainzl, S. Riegelsberger, C. Brauchle, M. P. Mayer, J. Buchner, R. D. Issels, and E. Noessner
Human Heat Shock Protein 70 Enhances Tumor Antigen Presentation through Complex Formation and Intracellular Antigen Delivery without Innate Immune Signaling
J. Biol. Chem.,
October 26, 2007;
282(43):
31688 - 31702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Csoka, Z. H. Nemeth, L. Virag, P. Gergely, S. J. Leibovich, P. Pacher, C.-X. Sun, M. R. Blackburn, E. S. Vizi, E. A. Deitch, et al.
A2A adenosine receptors and C/EBP{beta} are crucially required for IL-10 production by macrophages exposed to Escherichia coli
Blood,
October 1, 2007;
110(7):
2685 - 2695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Desrosiers, K. M. Cembrola, M. J. Fakir, L. A. Stephens, F. M. Jama, A. Shameli, W. Z. Mehal, P. Santamaria, and Y. Shi
Adenosine Deamination Sustains Dendritic Cell Activation in Inflammation
J. Immunol.,
August 1, 2007;
179(3):
1884 - 1892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lokshin, T. Raskovalova, X. Huang, L. C. Zacharia, E. K. Jackson, and E. Gorelik
Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells.
Cancer Res.,
August 1, 2006;
66(15):
7758 - 7765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. H. Nemeth, B. Csoka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Hasko
Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis
J. Immunol.,
May 1, 2006;
176(9):
5616 - 5626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Blocker, L. Berod, J. W. Fluhr, J. Orth, M. Idzko, K. Aktories, and J. Norgauer
Pasteurella multocida toxin (PMT) activates RhoGTPases, induces actin polymerization and inhibits migration of human dendritic cells, but does not influence macropinocytosis
Int. Immunol.,
March 1, 2006;
18(3):
459 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pacheco, J. M. Martinez-Navio, M. Lejeune, N. Climent, H. Oliva, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse
PNAS,
July 5, 2005;
102(27):
9583 - 9588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Idzko, E. Panther, C. Stratz, T. Muller, H. Bayer, G. Zissel, T. Durk, S. Sorichter, F. Di Virgilio, M. Geissler, et al.
The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release
J. Immunol.,
May 15, 2004;
172(10):
6011 - 6019.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|